Oral albendazole for the treatment of cutaneous larva migrans.

Abstract

Cutaneous larva migrans is becoming more common in the U.K. with the popularity of tropical countries as holiday destinations. We describe the increasing use of a new benzimidazole derivative, albendazole, which is very effective in the treatment of cutaneous larva migrans. In contrast to thiabendazole, it is virtually free from side-effects and should, we feel, become the treatment of choice for this condition.

• Authors: S K Jones, N J Reynolds, S Oliwiecki, R R Harman
• Journal: The British journal of dermatology (Br J Dermatol) Vol. 122 Issue 1 Pg. 99-101 (Jan 1990) ISSN: 0007-0963 [Print] England
• PMID: 2297509 (Publication Type: Journal Article)

Chemical References

• Albendazole

Topics

• Administration, Oral
• Albendazole (administration & dosage, therapeutic use)
• Breast (parasitology)
• Buttocks (parasitology)
• Humans
• Larva Migrans (drug therapy, parasitology)
• Leg Dermatoses (drug therapy, parasitology)